• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管内皮生长因子通过调节趋化因子受体CXCR4以自分泌方式促进乳腺癌侵袭。

Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4.

作者信息

Bachelder Robin E, Wendt Melissa A, Mercurio Arthur M

机构信息

Division of Cancer Biology and Angiogenesis, Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215, USA.

出版信息

Cancer Res. 2002 Dec 15;62(24):7203-6.

PMID:12499259
Abstract

We report that vascular endothelial growth factor (VEGF), a major angiogenic factor, is also arequisite autocrine factor for breast carcinoma invasion in vitro and that the VEGF receptor Neuropilin-1 but not Flt-1 is essential for this function. VEGF regulates expression of the chemokine receptor CXCR4, and this VEGF target is needed for invasion but not for cell survival. CXCR4 mediates migration of breast carcinoma cells toward stromal-derived factor-1, and this migration is dependent on autocrine VEGF. Of interest, a CXCR4-inhibitory peptide that is currently in HIV clinical trials suppressed invasion. Our findings indicate that a VEGF autocrine pathway induces chemokine receptor expression in breast carcinoma cells, thus promoting their directed migration toward specific chemokines.

摘要

我们报告称,血管内皮生长因子(VEGF)作为一种主要的血管生成因子,也是体外乳腺癌侵袭所必需的自分泌因子,且VEGF受体神经纤毛蛋白-1(Neuropilin-1)而非Flt-1对该功能至关重要。VEGF调节趋化因子受体CXCR4的表达,且该VEGF靶点是侵袭所必需的,但对细胞存活并非必需。CXCR4介导乳腺癌细胞向基质衍生因子-1的迁移,且这种迁移依赖于自分泌的VEGF。有趣的是,一种目前正在进行HIV临床试验的CXCR4抑制肽可抑制侵袭。我们的研究结果表明,VEGF自分泌途径可诱导乳腺癌细胞趋化因子受体表达,从而促进其向特定趋化因子的定向迁移。

相似文献

1
Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4.血管内皮生长因子通过调节趋化因子受体CXCR4以自分泌方式促进乳腺癌侵袭。
Cancer Res. 2002 Dec 15;62(24):7203-6.
2
[Inhibitation of tumor angiogenesis, growth and metastasis by blocking VEGF paracrine pathway].通过阻断VEGF旁分泌途径抑制肿瘤血管生成、生长和转移
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 2002 Mar;34(2):165-70.
3
Competing autocrine pathways involving alternative neuropilin-1 ligands regulate chemotaxis of carcinoma cells.涉及替代性神经纤毛蛋白-1配体的相互竞争自分泌途径调节癌细胞的趋化性。
Cancer Res. 2003 Sep 1;63(17):5230-3.
4
Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells.对基质细胞衍生因子-1进行基因操作证明了自分泌SDF-1-CXCR4通路在乳腺癌细胞侵袭性中的关键作用。
Int J Oncol. 2005 May;26(5):1429-34.
5
Blockade of the stromal cell-derived factor-1/CXCR4 axis attenuates in vivo tumor growth by inhibiting angiogenesis in a vascular endothelial growth factor-independent manner.阻断基质细胞衍生因子-1/CXCR4轴以不依赖血管内皮生长因子的方式抑制血管生成,从而减弱体内肿瘤生长。
Cancer Res. 2005 Jul 1;65(13):5864-71. doi: 10.1158/0008-5472.CAN-04-3833.
6
Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.血管内皮生长因子(VEGF)及其受体(Flt-1和Flk-1)在食管鳞状细胞癌中的表达
Anticancer Res. 2002 Nov-Dec;22(6C):3977-84.
7
Procollagen I COOH-terminal fragment induces VEGF-A and CXCR4 expression in breast carcinoma cells.前胶原蛋白I羧基末端片段诱导乳腺癌细胞中VEGF-A和CXCR4的表达。
Exp Cell Res. 2008 Jul 1;314(11-12):2289-98. doi: 10.1016/j.yexcr.2008.04.016. Epub 2008 May 10.
8
In vitro and in vivo angiogenesis in PC12 pheochromocytoma cells is mediated by vascular endothelial growth factor.PC12嗜铬细胞瘤细胞的体外和体内血管生成由血管内皮生长因子介导。
Exp Clin Endocrinol Diabetes. 2002 Nov;110(8):386-92. doi: 10.1055/s-2002-36424.
9
Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype.肿瘤细胞与淋巴管相互作用中的血管内皮生长因子-C和C-C趋化因子受体7促进侵袭性表型。
Cancer Res. 2009 Jan 1;69(1):349-57. doi: 10.1158/0008-5472.CAN-08-1875.
10
CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers.CXCL12与血管内皮生长因子协同诱导人卵巢癌新生血管形成。
Cancer Res. 2005 Jan 15;65(2):465-72.

引用本文的文献

1
TLR9 Downregulation in Breast Cancer: Its Role in Tumor Immunity, Inflammatory Response, and Cellular Senescence.乳腺癌中Toll样受体9的下调:其在肿瘤免疫、炎症反应和细胞衰老中的作用
J Innate Immun. 2025;17(1):354-368. doi: 10.1159/000545527. Epub 2025 Jun 23.
2
TMEM9 promotes lung adenocarcinoma progression via activating the MEK/ERK/STAT3 pathway to induce VEGF expression.跨膜蛋白9(TMEM9)通过激活MEK/ERK/STAT3信号通路诱导血管内皮生长因子(VEGF)表达,从而促进肺腺癌进展。
Cell Death Dis. 2024 Apr 25;15(4):295. doi: 10.1038/s41419-024-06669-8.
3
The transcriptional regulatory network modulating human trophoblast stem cells to extravillous trophoblast differentiation.
调节人滋养层干细胞向绒毛外滋养层分化的转录调控网络。
Nat Commun. 2024 Feb 12;15(1):1285. doi: 10.1038/s41467-024-45669-2.
4
CXC chemokine receptor 4 (CXCR4) blockade in cancer treatment.CXC 趋化因子受体 4(CXCR4)在癌症治疗中的阻断作用。
J Cancer Res Clin Oncol. 2023 Aug;149(10):7945-7968. doi: 10.1007/s00432-022-04444-w. Epub 2023 Mar 11.
5
Upregulation of sphingosine kinase 1 in response to doxorubicin generates an angiogenic response via stabilization of Snail.阿霉素诱导的鞘氨醇激酶 1 上调通过稳定 Snail 产生血管生成反应。
FASEB J. 2023 Mar;37(3):e22787. doi: 10.1096/fj.202201066R.
6
Epidemiologic, Genetic, Pathogenic, Metabolic, Epigenetic Aspects Involved in NASH-HCC: Current Therapeutic Strategies.非酒精性脂肪性肝炎-肝细胞癌涉及的流行病学、遗传学、致病性、代谢、表观遗传学方面:当前治疗策略
Cancers (Basel). 2022 Dec 20;15(1):23. doi: 10.3390/cancers15010023.
7
Multifunctional Plant Virus Nanoparticles for Targeting Breast Cancer Tumors.用于靶向乳腺癌肿瘤的多功能植物病毒纳米颗粒。
Vaccines (Basel). 2022 Aug 30;10(9):1431. doi: 10.3390/vaccines10091431.
8
Comprehensive Computational Analysis of Honokiol Targets for Cell Cycle Inhibition and Immunotherapy in Metastatic Breast Cancer Stem Cells.厚朴酚对转移性乳腺癌干细胞细胞周期抑制和免疫治疗靶点的综合计算分析
Evid Based Complement Alternat Med. 2022 Jul 8;2022:4172531. doi: 10.1155/2022/4172531. eCollection 2022.
9
CXCL12 promotes CCR7 ligand-mediated breast cancer cell invasion and migration toward lymphatic vessels.CXCL12 促进 CCR7 配体介导的乳腺癌细胞向淋巴管的侵袭和迁移。
Cancer Sci. 2022 Apr;113(4):1338-1351. doi: 10.1111/cas.15293. Epub 2022 Feb 14.
10
Investigating CXCR4 expression of tumor cells and the vascular compartment: A multimodal approach.研究肿瘤细胞和血管区室的 CXCR4 表达:一种多模态方法。
PLoS One. 2021 Nov 18;16(11):e0260186. doi: 10.1371/journal.pone.0260186. eCollection 2021.